Clinical Trial Update: A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study to evaluate how SHR7280 affects the PK of several drugs (midazolam, warfarin S-enantiomer, omeprazole, digoxin, and rosuvastatin) …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis
• Uterine Fibroids

Drugs mentioned

• DIGOXIN (Digoxin)
• Midazolam (Midazolam)
• Omeprazole (Omeprazole)
• Rosuvastatin (rosuvastatin)
• SHR7280
• Warfarin (S-enantiomer) (S-warfarin)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Endometriosis, Uterine Fibroids | Phase 1 | Status: COMPLETED